发明名称 Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension
摘要 Prostaglandin conjugates and derivatives and methods for their use to treat glaucoma and/or lower intraocular pressure are disclosed. Additionally, ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma and elevated intraocular pressure are disclosed. Such compositions comprise an effective amount of prostaglandin conjugates or derivatives of the present invention.
申请公布号 US9604949(B2) 申请公布日期 2017.03.28
申请号 US201514884074 申请日期 2015.10.15
申请人 Novartis AG 发明人 Ellis David Archer;Scheibler Lukas;Sharif Najam A.
分类号 A61K31/5575;C07D295/28;A61K31/559;A61K45/06;C07C205/49;A61K9/00;A61K9/08 主分类号 A61K31/5575
代理机构 代理人 Flanigan Mark
主权项 1. An ophthalmic pharmaceutical composition useful in the treatment of glaucoma and control of intraocular pressure, comprising an effective amount of a compound (I) of the following formula: in which A is selected from the group consisting of: where: n is 1-6; R1, R2, R3 independently=OH or O—NO2; R4, R5 independently=H, alkyl, or heteroalkyl; or R4 and R5 can combine to form cyclic alkyl or cyclic heteroalkyl; and R6 independently=H, NO2, organic nitrate, organic nitrite, metal —NO complex, sodium nitroprusside (SNP), dinitrosyl iron thiol complex (DNICs), N-nitrosamine, N-hydroxy-N-nitrosamine, N-nitrosimine, nitrosimine, C-nitroso, diazetine dioxide, furoxan, benzofuroxan, oxatriazole-5-imine, sydnonimine, oxime, hydroxylamine, N-hydroxyguanidine, or hydroxyurea; and a pharmaceutically acceptable vehicle therefor.
地址 Basel CH